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Complex aortic disease continues to have a high mortality and morbidity despite advances in medical and surgical
treatment. Repair of thoracoabdominal aneurysms, treatment of patients with connective tissue disorders, and the
approach to dissections of the ascending and descending aorta have evolved over time; however, the results of intervention
in all but highly specialized centers remain poor. As vascular surgeons, our role must extend beyond that of the pure
technician; we have been vested with the life-long care of these patients and, therefore, have a responsibility to the patient
in addition the scientific community and society at large to create a strategy for management that serves all three interests
justly. We will outline some of the changes in the conceptual approach that we consider important to the treatment of
complex aortic disease. ( J Vasc Surg 2008;48:17S-23S.)THORACOABDOMINAL ANEURYSM
Open thoracoabdominal aortic aneurysm (TAAA) re-
pair was first reported by Etheredge in 1955.1He described
the use of a polyethylene shunt to assist with the placement
of an aortic homograft, anastomosed systematically using
4-0 cardiovascular silk to the celiac and superior mesenteric
arteries, as well as proximal and distal aorta, with resection
of the left kidney and intervening aneurysmal aorta.
DeBakey subsequently presented the first series of cases in
1956,2 where he emphasized the use of a shunt to prevent
prolonged end-organ ischemia. By 1965 DeBakey’s group
had amassed 42 cases and reported an operativemortality of
26%.3 Modifications on the original technique, specifically
the use of a Carrell patch4 to expedite revascularization of
the mesenteric vessels and minimize ischemia time, were
proposed by Crawford and heralded the onset of a series of
incremental improvements in the operative management of
complex aortic repair.5
Now, modern series of elective TAAA repair from
single-center, high-volume institutions report compara-
tively low mortality rates (Table),6-15 but these results are
not likely to reflect the true efficacy of the operation.
Aggregate data that include outcomes from institutions
with lower volume or limited expertise, such as reported by
Rigberg et al,16 do not reflect the same perioperative suc-
cess. In the Rigberg report, the elective operative mortality
was 19% at 30 days and 31% at 1 year.16
A disappointing finding was that the highest volume
centers in this series performed only seven to 14 TAAA cases
per year, suggesting that volume is likely associated with
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even prospective studies that have evaluated open TAAA
surgery outcomes that may be used to help with the decision
making regarding the risks and benefits of treatment.
Mortality alone is not a sufficient metric on which to
base conclusions about TAAA repair. Serious morbidities
have also been associated with the open approach, includ-
ing spinal cord injury, stroke, and renal dysfunction. When
combined with mortality, complications of open surgery
have been frequent even in high-volume institutions. At
institutions with reported perioperative mortality rates (6%
to 9%), spinal cord ischemia has been reported in up to
15.5% of patients (range, 1.4%-15.5%), and renal compli-
cations occur in as many as 21% (range, 5.6-21). The
reported outcomes challenge the role for open surgical
treatment of extensive TAAA in institutions other than
highly specialized open vascular surgery centers and call for
an innovative new approach.
ACUTE AORTIC DISSECTION
Acute aortic dissection was found in 3.5 per 100,000
population (95% confidence interval [CI], 2.4-4.6) in a
population-based study fromOlmsted County, Minnesota.17
In that review, 85% of dissections occurred in the ascending
aorta and 15% in the descending. The survival rate was
dismal in the mid-20th century, with a 5-year survival of 5%
between 1951 and 1980, and demonstrated a moderate
improvement to 32% between 1980 and 1994 as a result of
improved early diagnosis, surgical techniques, and nonop-
erative medical management.18
The treatment for acute dissection is tailored to the ana-
tomic regions involved. When the ascending aorta is affected,
the risk of deterioration as a result of dissection progression to
involve the aortic valves, coronary vasculature, or rupture into
the pericardium is significant. The treatment for this condition
is ascending aortic replacement.
The Stanford experience of acute proximal dissections
from 1963 to 1982 was associated with a perioperative mor-
tality of 42%  10%, which dropped to 27%  7% between
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reporting a 19.6% perioperative mortality for type A dissec-
tion20 and the International Registry of Acute Aortic Dissec-
tion (IRAD), which reported an in-hospital mortality of 26%
for type A.21 A review of the national database in Taiwan
(1996 to 2001) stratified outcomes for acute typeAdissection
by age 70 or 70 years. They found that contemporary
perioperative mortality rates averaged 25% at 30 days for both
groups.22 Likewise, review of the Nationwide Inpatient Sam-
ple in theUnited States revealed an inhospitalmortality rate of
26% for the study period of 1995 to 2003.23 However in
keeping with the trend in TAAA, other authors, notably at
high-volume centers, have estimated more significant im-
provements in contemporary series.24,25
Detailed study of aortic dissection has evolved an ap-
preciation of the continuum of disease that can be found
when a patient presents with what is now termed “acute
aortic syndrome.”26,27 The treatment for penetrating ulcer
and the management of intramural hematoma has evolved
during the last decade, and an understanding of the com-
mon pathologies has had an effect on management.27
Several factors have been noted to drive patient manage-
ment decisions. The location of the primary fenestration
may have an effect on outcome.28 Other disease variants
such as intramural hematoma and nonperfused false lumen
have been observed to have better outcome,29 whereas
periaortic hematoma,30 concurrent acute coronary symp-
toms,31 and cocaine use32 are predictive of poor outcome.
Late outcomes after intervention for type A dissection
do not provide any further encouragement. The data from
the national database in Taiwan revealed a freedom from
mortality of 56% at 6 years.20 Results from a single-center
experience showed that the risk of reoperation at 10 years
was 16% in the type A group, and late risk of death is
approximately twice that of the healthy population.33 The
late cause of death in patients who are treated operatively
for acute proximal dissections has historically been aortic
rupture (29%15 and 12%33), cardiac death (16%20 and
26%33), and neurologic causes (16%20 and 9%20).
In contrast to acute type A dissection, the role of the open
Table. Mortality and rates of spinal cord injury in
patients undergoing thoracoabdominal aortic aneurysm
repair at specialized institutions
Trial, year No.
Mortality, No.
(%)
Spinal cord injury,
No.
Coselli,6 2007 2286 150 (6.56) 87 (3.81)
Schepens,7 2007 500 62 (12.40) N/A
Etz,8 2007 858 83 (9.67) 10 (1.17)
Achneck,9 2007 130 N/A (11.9) 5 (14.29)
Conrad,10 2007 455 39 (8.57) 43 (9.66)
Fehrenbacher,11
2007 110 5 (4.55) 5 (4.55)
Jacobs,12 2004 279 24 (8.60) 4 (1.43)
Safi,13 2005 1106 162 (14.65) 36 (3.25)
Grabitz,14 1996 260 37 (14.23) 6 (2.31)
Svensson,15 1993 1509 123 (8.15) 234 (15.51)operative approach for acute type B dissection has evolvedduring the last 4 decades, from primary operative manage-
ment to a nonoperative strategy involving an aggressive med-
ical therapy in the absence of complications such as rupture or
malperfusion. The reasoning for this approach relates to the
dismal surgical outcomes when early operative treatment is
attempted in conjunction with the reasonable results associ-
ated with pure medical management.21,34
The Stanford group reported acute type B dissection
perioperative outcomes and found that they decreased from
43% 13% to 20% 19% from the time intervals of 1963 to
1976 and 1988 to 1992, respectively. Similarly, the IRAD
database reports a contemporary mortality of 31% for acute
type B dissections treated surgically.21 It is important to take
note of this history in the era of endovascular repair, where
some authors advocate early intervention in type B dissection
even in the absence of conventional surgical indications.35
Further evidence lies in themedical arm of the single random-
ized trail for acute type B dissection, had notably few compli-
cations through two years of follow-up (personal communi-
cation from C. Nienaber).
ROLE OF THE ENDOVASCULAR APPROACH
In the context of the sustained poor outcomes outside
of centers of excellence reported in the literature for both
TAAA and acute aortic dissection, it follows that a mini-
mally invasive approach would be welcome and may be
beneficial. However, much like the trend demonstrated
above, the same may be echoed in the endovascular treat-
ment of the above diseases: Except for a small sample of
reported good outcomes from high-volume, expertise-
dense centers, the outcomes for endovascular intervention
of complex aortic disease have been guarded. As reporting
standards become more stringent, challenges will arise in
the ability to interpret the applicability of outcomes re-
ported heterogeneous populations that may be used to
imply efficacy and safety of the interventions themselves.
Few series have studied the role of endovascular repair
for TAAA. Early-generation techniques such as mesenteric
bypass procedures coupled with endovascular aortic relin-
ing confer high-risk solutions where the perioperative re-
sults are still associated with a mortality as high as 23%
(range, 12%-23%).36-40 A few groups have reported series
of branched endografts (Fig 1) in patients considered to be
high operative risk, with mortality ranging from 0% to
9%.41-43 Because of the technical challenges associated with
the technique, widespread utilization has not been re-
ported, thus its adoption as a replacement for open repair
remains untested.
The endovascular approach to type B dissection is the
subject of much debate, with variable agreement on the
timing and indications for repair and a great deal of heter-
ogeneity in the patients included in reports of acute or
chronic outcomes. Endovascular intervention for patients
with acute, symptomatic, or complicated type B dissection
is accepted as an option by most; however, the procedure
performed varies, with some groups suggesting septal fen-
estration, simple branch stenting, or thoracic endografting,
depending on the clinical scenario.44-46
JOURNAL OF VASCULAR SURGERY
Volume 48, Number 6S Mastracci and Greenberg 19SA recent review of penetrating aortic ulcer described
the risk of death, endoleak, and spinal ischemia in the
available published series and found that perioperativemor-
tality ranges from 0% to 12%.47 One high-volume center
that uses central aortic fenestration and renal artery stenting
as a treatment for malperfusion complicating acute dissec-
tion reports a perioperative mortality of 21%.44 Other
groups, reporting on their experience in both the acute and
chronic thoracic aortic population, found a perioperative
mortalities of 5% to 16%, but these results are difficult to
interpret because of the heterogeneity of the patients un-
dergoing intervention.45,48-51
THE SURGEON’S RESPONSIBILITY
Balancing accountability to patients, the scientific com-
munity, and the society in which we live provides the
parameters within which further progress in the treatment
of complex aortic disease will be made.
From a patient-care perspective, finding a treatment ap-
proach that confers the maximum benefit with minimal inva-
siveness and expedites rapid and complete recovery is the aim.
Thismandates an outcomes-driven approach, where clinicians
with greatest expertise are vested with the dual responsibilities
of providing both excellent patient care and detailed out-
come-driven training to emerging professionals. An environ-
ment that best serves the needs of clinicians dedicated to
innovative and effective treatment should be developed.
Our accountability to society lies in creating an ap-
proach to complex aortic disease that emphasizes distribu-
Fig 1. This three-dimensional reconstruction of a computed to-
mography scan of a fenestrated endograft in situs shows the
incorporation of renal and superior mesenteric arteries. The un-
covered stent is apposing the celiac orifice. Postprocessing software
provides the ability to interrogate the repair to assess stent integrity
and aneurysm sac changes.tive justice. Our understanding of mortality can be ex-pressed as a sum of two factors: one age-dependent and one
age-independent (the Gompertz-Makeham Law).52,53 Ba-
sic improvements in health care through the early 19th
century, such as effective treatments for infection and trau-
matic injury, have decreased the age-independent factors
and contributed to the rectangularization of the survival
curve.54 Pursuit of more effective treatments for conditions
known to shorten survival will mean that a greater fraction
of society will continue to thrive and contribute at older
ages, using fewer health care resources for chronic or de-
bilitating conditions.
Applying this theory to aortic disease requires two funda-
mentals: first, a treatment that eliminates the risk of aortic
mortality but returns the patient back to a normal level of
functioning; and second, the ability to identify, among a
group of patients with multiple life-threatening comorbidi-
ties, those who are most likely to die from aortic causes.
Investing in an approach that fulfills these criteria is the most
just method of distributing limited health care resources.
Surgeons’ accountability to the scientific community
implies that effective and innovative treatments, distributed
justly, should be developed and tested using rigorous sci-
entific methods in a timely fashion. Providing care that
meets the highest standards of clinical excellence requires
that the rate of investigation and testing of new treatments
keeps pace with the rate of emerging technology. Thus, it
follows that innovation in basic science, methodologic, and
statistical techniques will have to be as rich and creative as
that which is applied to aortic disease itself. Authors who
question the role of evidence-based surgery and, specifi-
cally, randomized controlled trials, cite an intrinsic lack of
individual equipoise, challenges with blinding or inherent
bias.55 However, alternate methods have been proposed,
such as expertise-based randomized controlled trials56 that
address these concerns and provide a framework for the
testing of new devices. The recent upsurge in the use of
propensity score analysis for observational data is another
example of how creative statistical innovation can increase
the strength of evidence for emerging treatments.57,58
CHANGING THE APPROACH: PERCEPTION
AND MANAGEMENT
Changes in the conventional approach to aortic disease
are necessary because the diseases themselves have taken on
a Hausdorff dimension. The new paradigm for care of the
aorta involves clinicians from multiple disciplines with di-
verse skills sets and training programs that cross traditional
boundaries. Evaluating the patient with aortic disease has,
in many circumstances, evolved into a multidisciplinary
pursuit. Acute aortic syndrome is one example of how
improved ability to differentiate among aortic dissection,
intramural hematoma, and penetrating ulcers has affected
management strategies.
Another important paradigm shift has come with a
deepening appreciation of the hereditary nature of many
forms of aortic disease. Connective tissue disorders such as
Marfan syndrome59 have been described for years, and the
quest for other uncharacterized genetic links has intensi-
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terns, such as Loeys-Dietz syndrome.61 It is estimated that
21% of non-Marfan patients presenting with aneurysm have
some family member with aneurysmal disease, and TAAs
have a predominant autosomal dominant mode of inheri-
tance with variable penetrance and expressivity.62Monitor-
ing this group reveals that familial TAAAs grow at a higher
rate relative to aneurysms that occur sporadically and even
aneurysms associated with Marfan syndrome.62
Furthermore, the differentiation of ascending, de-
scending, and abdominal aortic disease is also likely genet-
ically linked.62 Pathologic comparison of specimens taken
from Marfan and non-Marfan aneurysmal aortas have very
similar features, with the Marfan tissue merely demonstrat-
ing a greater quantity of tissue degeneration.63
Certainly, in our practice, the role of transforming growth
factor  (TGF-) in the diagnosis and investigation of such
disorders is becomingmore important as we routinely involve
themedical geneticist in the plan of care to coordinate genetic
testing and provide genetic counseling to younger patients
(60 years old) presenting with aortic disease.
CHANGING THE APPROACH: EVALUATION
Imaging for the aorta is also rapidly evolving. The endo-
vascular era has ushered in an expansion in the noninvasive
imaging technology necessary for planning and evaluation, so
that diagnostic angiography is becoming extinct. Isotropic
voxel resolution from 64 slice computed tomography (CT)
scans has enhanced postprocessing algorithms and enabled
more accurate multiplanar reconstructions. Thus in the ab-
sence of a contraindication, CT scanning has become the
standard of care for cardiovascular imaging,64,65 given that a
broad range of conditions can be assessed, making it both
versatile and more economically feasible.66 Center lumen of
flow analysis is essential to the planning of the repair of most
complex endovascular approached to aortic disease, such as
branched and fenestrated endografts,67 (Fig 2) and now vas-
cular surgeons are often trained in postprocessing software
and image interrogation.
THE FUTURE: AUTOMATION, ENGINEERING
AND ETIOLOGY
The future of treatment for complex aortic disease lies
in use of minimally invasive technology and growing an
expertise base. The challenge will be at the convergence of
innovation that simplifies and standardizes procedures with
the development of training programs and implementation
of techniques to maintain benchmark outcomes. The
Cleveland Clinic is changing its approach to aortic disease
by creating an Aortic Institute that will combine expertise
in multiple disciplines to strengthen treatment options.
The current process to design and plan an endovascular
TAAA repair requires knowledge of graft engineering, and
the experience that has been accrued by a few individuals in
the field is very difficult to replicate and limits its widespread
use. However, because most errors arise during the plan-
ning stages of the procedure, creation of a semiautomated
process to measure and design the grafts may expand thefeasibility of the technique and decrease the time-intensive
process of measurement and graft design. The goal of
automation of this process is to find the balance that will
increase precision of assessing the geometric relationships
while allowing the physician user to determine the critical
Fig 2. The strategy of approach for complex cases, such as en-
dograft failures, are facilitated using postprocessing imaging,
which provides the needed detail and relational anatomy to size
and plan a repair in the presence of a previous device. A, A failed
aortic endograft is depicted, and the short-bodied graft design and
crossed limbs will have ramifications for repair. B, A different
patient who has had an endo-to-endo conversion of an original
aortic repair is shown.aspects of treatment that require clinical judgment.
omet
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mathematic model based on Digital Imaging and Commu-
nications in Medicine (DICOM; NEMA, Rosslyn, Va) CT
data to create geometric analysis of aortic dimensions in an
efficient and reproducible way and has evaluated this
against traditional measurement techniques (Fig 3).68 This
work demonstrates that a mathematic algorithm can be
developed to measure critical aortic dimensions of TAAA
for the purpose of automated graft design with an accept-
able degree of error compared with individual expert mea-
surements, although more work needs to be done. Models
that are created for planning and sizing of endografts can
then be used in concert with the procedures using registra-
tion processes, allowing physicians to visualize the proce-
dure in three, rather than two, dimensions.
Devices and delivery systems have undergone iterative
improvements for conventional applications in infrarenal an-
eurysms and descending thoracic aneurysms. Systems have
been developed and used clinically that readily navigate the
entire aorta, allowing endovascular treatment of the ascending
aorta. The curvature of the arch, variability of the rotational
alignment of the supra-aortic trunks, and the anatomic limi-
tations of the proximal ascending aorta have posed ahurdle for
graft design at present, but the experience being gained with
visceral devices will certainly inform the evolution of devices
that are steerable, even within the inherent tortuosity of the
aortic arch. Implants also have undergone improvements. It is
unusual to find tears within the fabric of endografts, and stent
fractures have become increasingly less common.
Yet late failures are reported at an alarming rate, many
likely because of an under-appreciation of the extent of the
aneurysmal disease, resulting in device fixation or sealing in
unhealthy aorta. Although this may be due to an inability to
assess the true extent of the disease, often it relates to the
Fig 3. A computed tomography scan during a patien
generated using our geometric analyses. Left, The inte
superimposed in a wire frame.Right,The same surface is
of the geometry. (Permission to reproduce granted b
Greenberg DP, Greenberg RK. Automated Vascular Gelimits imposed by adding complexity to the repair (open orendovascular) such as the visceral or internal iliac arterial
branches. Early devices capable of maintaining flow to
critical aortic branches have been used clinically in thou-
sands of patients already. New devices that require less
customization have more simplified implantation para-
digms and may combat some of the recognized late com-
plications are under investigation.
The implementation of individualized methods of pre-
dicting the long-term survival of patients juxtaposed with
their risk of an aortic-related death is underway. Improved
methods for determining rupture risk, coupled with vali-
dated scoring systems capable of assessing perioperative and
long-term risk, must be used to appropriately recommend
intervention. Current treatment paradigms result in the
lumping of patients into surgically fit or unfit groups, yet
the means and validation of the discrimination process is
subject to skepticism.
Finally, even more research and understanding will
need to be gained with respect to the etiology and natural
history of the diseases of the aorta. Understanding the role
of intervention in complex aortic diseases, such as aortic
dissection or TAAA, will only be achieved if the mecha-
nisms of disease are understood. That knowledge will af-
ford us the ability to determine who requires treatment, the
ability to properly treat patients, provide counseling to
relatives, and limit the debilitating and often fatal aspects of
this complex disease.
In conclusion, the next generation of discovery in
aortic disease will focus less on the characterization of new
disease entities and more on the exploration of the com-
plexities that lurk below the surface of the conditions we
already know. Creating an environment to house innova-
tion in all aspects of training, treatment, and investigation
orkup for aortic repair is shown with analytic surfaces
-cropped arterial scan. Middle, The analytic surface is
n rendered with a shadingmodel to show the complexity
EE Computer Graphics and Applications. Goel VR,
ric Analysis of Aortic Aneurysms, Figure 10c).t’s w
nsity
show
y IEwill be the challenge for the future.
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DrK. Craig Kent (New York, NY). Is this something that the
average vascular surgeon can ever accomplish, or is this a procedure
that is going to be taken care of in selective institutions around the
world?
Dr Roy Greenberg. Well, I think that thoracoabdominal
aneurysm repair is something that is done in centers with a lot of
expertise. But I think that the actual technical requirements of
doing a branched endograft are not that different than an open
aneurysm repair, once you understand the principles.
Much like the presentation from Japan, where they have
struggled with how to train someone to size an arch device, with all
these complex branches, it requires knowledge, time, and under-
standing. They have a single individual to size all devices, while we
prefer that the individual treating physician design each device. WeHow can we put it in the hands of everyone to say, okay, you want
a branch device, here is how you design it. This is in the form of a
computer program involving mathematical modeling. This was
recently published in JVS (Journal of Vascular Surgery) and by
IEEE (Institute of Electrical and Electronics Engineers) and it
allows the physician to determine the proximal extent of the repair
and then determines the geometric configuration of the specified
branches. This allows for a semi-automated design.
Critically, it is the treating physician that is still making the
decisions. This is a really important thing. It allows clinicians
develop judgment based on who does well with different designs,
and the amount of the aorta that can be repaired safely in a given
patient and the extent of the repair. You can’t send your films off to
someone else and say design me a device, without any context of
the patient and the other comorbidities.
